CFIHX
Price
$68.09
Change
-$0.65 (-0.95%)
Updated
Apr 10 closing price
Net Assets
104.37B
PGDRX
Price
$10.73
Change
-$0.10 (-0.92%)
Updated
Apr 10 closing price
Net Assets
2.33B
Ad is loading...

CFIHX vs PGDRX

Header iconCFIHX vs PGDRX Comparison
Open Charts CFIHX vs PGDRXBanner chart's image
American Funds Capital Income Bldr F3
Price$68.09
Change-$0.65 (-0.95%)
VolumeN/A
Net Assets104.37B
Principal Diversified Real Asset R3
Price$10.73
Change-$0.10 (-0.92%)
VolumeN/A
Net Assets2.33B
CFIHX vs PGDRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFIHX vs. PGDRX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIHX is a Hold and PGDRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CFIHX has more cash in the bank: 104B vs. PGDRX (2.33B). CFIHX pays higher dividends than PGDRX: CFIHX (3.47) vs PGDRX (1.29). CFIHX was incepted earlier than PGDRX: CFIHX (8 years) vs PGDRX (9 years). PGDRX (1.37) is less costly to investors than CFIHX (0.27). PGDRX has a lower initial minimum investment than CFIHX: PGDRX (0) vs CFIHX (1000000). CFIHX annual gain was more profitable for investors over the last year : 6.56 vs. PGDRX (-0.51). CFIHX return over 5 years is better than : 42.47 vs. PGDRX (25.47).
CFIHXPGDRXCFIHX / PGDRX
Total Expense Ratio0.271.3720%
Annual Report Gross Expense Ratio0.271.3720%
Fund Existence8 years9 years-
Gain YTD0.456-1.940-24%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets104B2.33B4,456%
Annual Yield % from dividends3.471.29269%
Returns for 1 year6.56-0.51-1,289%
Returns for 3 years10.10-15.34-66%
Returns for 5 years42.4725.47167%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAFDP15.87-0.43
-2.64%
WaFd
VRNT15.46-0.61
-3.80%
Verint Systems
RKLB19.63-0.96
-4.66%
Rocket Lab USA
CCCC1.21-0.09
-6.92%
C4 Therapeutics
ESPR0.96-0.09
-8.57%
Esperion Therapeutics